The tumor size, nodal status, distant metastases, MSI instability, presence of BRAF and RAS mutations, or a combination of these factors are among the poor prognostic factors; however, in the study, histological poor prognostic factors, such as lymphovascular invasion, perineural invasion, and tumor necrosis, were also considered for analysis. The gene discussed is BRAF; the disease is neoplasm.